Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 Feb;33(1):25-31.
doi: 10.1007/s10545-009-9030-9. Epub 2010 Feb 2.

A potential role for muscle in glucose homeostasis: in vivo kinetic studies in glycogen storage disease type 1a and fructose-1,6-bisphosphatase deficiency

Hidde H Huidekoper  1 , Gepke Visser, Mariëtte T Ackermans, Hans P Sauerwein, Frits A Wijburg
Affiliations
Case Reports

A potential role for muscle in glucose homeostasis: in vivo kinetic studies in glycogen storage disease type 1a and fructose-1,6-bisphosphatase deficiency

Hidde H Huidekoper et al. J Inherit Metab Dis. 2010 Feb.

Abstract

Background: A potential role for muscle in glucose homeostasis was recently suggested based on characterization of extrahepatic and extrarenal glucose-6-phosphatase (glucose-6-phosphatase-beta). To study the role of extrahepatic tissue in glucose homeostasis during fasting glucose kinetics were studied in two patients with a deficient hepatic and renal glycogenolysis and/or gluconeogenesis.

Design: Endogenous glucose production (EGP), glycogenolysis (GGL), and gluconeogenesis (GNG) were quantified with stable isotopes in a patient with glycogen storage disease type 1a (GSD-1a) and a patient with fructose-1,6-bisphosphatase (FBPase) deficiency. The [6,6-(2)H(2)]glucose dilution method in combination with the deuterated water method was used during individualized fasting tests.

Results: Both patients became hypoglycemic after 2.5 and 14.5 h fasting, respectively. At that time, the patient with GSD-1a had EGP 3.84 micromol/kg per min (30% of normal EGP after an overnight fast), GGL 3.09 micromol/kg per min, and GNG 0.75 micromol/kg per min. The patient with FBPase deficiency had EGP 8.53 micromol/kg per min (62% of normal EGP after an overnight fast), GGL 6.89 micromol/kg per min GGL, and GNG 1.64 micromol/kg per min.

Conclusion: EGP was severely hampered in both patients, resulting in hypoglycemia. However, despite defective hepatic and renal GNG in both disorders and defective hepatic GGL in GSD-1a, both patients were still able to produce glucose via both pathways. As all necessary enzymes of these pathways have now been functionally detected in muscle, a contribution of muscle to EGP during fasting via both GGL as well as GNG is suggested.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study protocols in patients 1 [glycogen storage disease type 1a (GSD-1a)] and 2 [fructose-1,6-bisphosphatase (FBPase)] deficiency
Fig. 2
Fig. 2
Glucose kinetics in relation to plasma glucose concentration and fasting duration in a patient with glucose-6-phosphatase deficiency (GSD-1a). Plasma glucose concentrations are depicted in the left panel (A). Endogenous glucose production (EGP; ●), glycogenolysis (GGL; ▲) and gluconeogenesis (GNG; ▼) are depicted in the right panel (B)
Fig. 3
Fig. 3
Glucose kinetics in relation to plasma glucose concentration and fasting duration in a patient with fructose-1,6-bisphosphatase (FBPase) deficiency. Plasma glucose concentrations are depicted in theleft panel (A). Endogenous glucose production (EGP; ●), glycogenolysis (GGL; ▲) and gluconeogenesis (GNG; ▼) are depicted in theright panel (B)
See this image and copyright information in PMC

References

    1. Ackermans MT, Pereira Arias AM, Bisschop PH, Endert E, Sauerwein HP, Romijn JA. The quantification of gluconeogenesis in healthy men by 2H2O and [2-13C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with 2H2O are higher than those measured with [2-13C]glycerol. J Clin Endocrinol Metab. 2001;86:2220–2226. doi: 10.1210/jc.86.5.2220. - DOI - PubMed
    1. Adams A, Redden C, Menahem S. Characterization of human fructose-1, 6-bisphosphatase in control and deficient tissues. J Inherit Metab Dis. 1990;13:829–848. doi: 10.1007/BF01800207. - DOI - PubMed
    1. Baker L, Winegrad AI. Fasting hypoglycaemia and metabolic acidosis associated with deficiency of hepatic fructose-1, 6-diphosphatase activity. Lancet. 1970;2:13–16. doi: 10.1016/S0140-6736(70)92474-8. - DOI - PubMed
    1. Bier DM, Leake RD, Haymond MW, et al. Measurement of “true” glucose production rates in infancy and childhood with 6, 6-dideuteroglucose. Diabetes. 1977;26:1016–1023. doi: 10.2337/diabetes.26.11.1016. - DOI - PubMed
    1. Bock G, Schumann WC, Basu R, et al. Evidence that processes other than gluconeogenesis may influence the ratio of deuterium on the fifth and third carbons of glucose: implications for the use of 2H2O to measure gluconeogenesis in humans. Diabetes. 2008;57:50–55. doi: 10.2337/db07-0694. - DOI - PubMed

Publication types